Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
Fructosamine is a blood test that measures the amount of glucose that has attached to proteins in your bloodstream, mainly albumin. Because these proteins turn over more quickly than red blood cells, the result reflects your average blood sugar over the past few weeks.
This test can complement or substitute for a hemoglobin A1c when a shorter-term view is needed or when A1c may be unreliable. It uses a routine blood draw, and results are interpreted alongside your overall health, including protein levels and conditions that affect protein balance.
For people with diabetes, fructosamine helps evaluate how well your treatment plan is working in the recent weeks. It can show changes sooner after starting or adjusting medicines, insulin, or nutrition and activity plans, and it can be useful when fingerstick or continuous glucose data are limited.
Fructosamine is especially helpful when A1c does not reflect true glucose levels, such as with some hemoglobin variants, recent transfusion, significant anemia, kidney disease treated with erythropoietin, or during pregnancy. The test itself is low risk and involves a simple blood draw performed in a clinical laboratory.
In general, higher fructosamine suggests higher average glucose in the recent weeks, and lower values suggest lower average glucose. If your result does not match your symptoms or home glucose checks, your clinician may look for factors that change protein levels or interfere with the assay and may consider repeating the test.
Your care team may pair fructosamine with albumin or total protein, A1c, capillary glucose logs, or continuous glucose data to build a complete picture. Trends over time are often more informative than a single result. Use the result with your clinician to guide practical next steps, such as medication adjustments, nutrition planning, and timing of follow-up.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Low albumin from liver disease, nephrotic syndrome, inflammation, or malnutrition can lower fructosamine independent of glucose. Conditions that increase protein turnover can lower values, while reduced turnover can raise them.
An overactive thyroid speeds protein turnover and may lower fructosamine, while an underactive thyroid slows turnover and may raise it. Interpreting results alongside thyroid status improves accuracy.
Kidney disease and liver disease can change the amount and type of circulating proteins, which can shift fructosamine results. Nephrotic-range protein loss, in particular, often lowers measured values.
is associated with lower albumin and fluid shifts, which can reduce fructosamine despite stable glucose. Discuss how pregnancy stage may affect interpretation and monitoring frequency.
High-dose vitamin C or other reducing agents may cause falsely low results. Intravenous immunoglobulin or paraproteins can raise measured fructosamine, and steroids can increase glucose levels.
Severe lipemia, hemolysis, or jaundice can interfere with some methods. Acute illnesses and recent major changes in treatment can shift results, so timing relative to these events matters.
References